Medica Superspecialty Hospital, the largest hospital chain in Eastern India, achieved significant milestones with the successful execution of the first ‘Chronic Total Occlusion (CTO) procedure on Impella support’ in Eastern India. The procedure was performed on a 66-year-old male patient from Dhakuria, Kolkata. This groundbreaking intervention, led by Dr. Dilip Kumar, Director-Cardiac Cath Lab Senior Consultant Interventional Cardiologist & Electrophysiologist, Chief Academic Co-Ordinator Medica Institute of Cardiac Science (MICS), highlights Medica’s prowess in advanced cardiac care. Assisting in the procedure was Dr. Dipanjan Chatterjee, Director ECMO and Thoracic Organ transplant program, Physician, Head Cardiopulmonary Care Specialist, Medica Superspecialty Hospital.
In a parallel achievement, Dr. Dilip Kumar successfully conducted the first-ever Balloon Mitral Valvuloplasty on Ms. Aarti Singh, a 33-year-old woman from Siliguri, who was in her 32nd week of a twin pregnancy at Medica Superspecialty Hospital.
The Impella device, known as the world’s smallest heart pumping machine, played a crucial role in the CTO procedure. Particularly useful in cases where conventional procedures pose heightened risks due to a weakened heart, the Impella device supports patients during critical situations, such as heart attacks. It allows a temporary takeover of crucial heart functions, offering a window of 4 to 6 hours for subsequent interventions. The Impella device is especially vital in severe artery blockages, providing essential support when intervention processes face delays. Its implementation has significantly extended the lifespan of patients grappling with complex heart diseases and proves instrumental when patients are awaiting heart transplants.
Dr. Dilip Kumar shared, “This particular case stands out as the first of its kind in India, and possibly worldwide. Here, we successfully performed the procedure on a woman expecting twins. Following the operation, she recovered well, and at the 36th week of her pregnancy, she gave birth to two healthy babies in Chhattisgarh.”
Regarding the Impella device, (Prof.) Dr. Rabin Chakraborty, Senior Consultant, Interventional Cardiologist & Electrophysiologist, Senior Vice Chairman-Head of Cardiology Services, Medica Institute of Cardiac Science (MICS), explained, “The Impella device is a compact ventricular assist device operating through a catheter, providing essential support to a failing heart during cardiogenic shock caused by a heart attack. It is also effective during high-risk angioplasties in patients with poor heart function, where surgery becomes extremely risky.”
Mr. Ayanabh Debgupta, Jt. Managing Director, Medica Group of Hospitals, expressed pride in the hospital’s achievements, stating, “Impella is emerging as a path-breaker in cardiac care. We are overwhelmed to be the first in the region to successfully implement the ‘Chronic Total Occlusion (CTO) procedure on Impella support.”
Mr. R. Udayan Lahiry, Managing Director, Medica Group of Hospitals, emphasized the commitment to clinical excellence and technological advancement, ensuring that patients receive optimal care for critical conditions. Both patients are reported to be doing well after the successful interventions, showcasing the positive impact of advanced cardiac procedures at Medica Superspecialty Hospital.
